Original Paper

Effects of Cigarette Smoking on Hematological Parameters and von Willebrand Factor Functional Activity Levels in Asymptomatic Male and Female Arab Smokers
Anwar M. Al-Awadhi^a, Suad M. AlFadhli^a, Nada Y. Mustafa^a, Prem N. Sharma<sup>b

a</sup>Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, and
^bHealth Sciences Computer Center, Kuwait University, Kuwait

Address of Corresponding Author

Med Princ Pract 2008;17:149-153 (DOI: 10.1159/000112970)

  Key Words

• Smoking
• Gender
• von Willebrand factor
• Enzyme-linked immunoassay

  Abstract

Objectives: This study aimed at determining the effects of cigarette smoking based on gender, on several hematological parameters and von Willebrand factor protein in the asymptomatic Arab population of Kuwait. Subjects and Methods: Ninety-two subjects participated in this study: 55 males (31 smokers and 24 nonsmokers) and 37 females (18 smokers and 19 nonsmokers). Complete blood count results were obtained using Beckman Coulter Hematology Analyzer. Von Willebrand factor functional activity was determined using an enzyme-linked immunoassay-based test in which anti-von Willebrand factor IgG monoclonal antibody was used that recognizes a functional epitope of the protein. The coagulation profile was obtained using ACL® 9000 coagulation analyzer. Results: Male smokers had significantly higher levels of white blood cell count (p = 0.03) and von Willebrand factor protein levels (p = 0.029), and a significantly shorter thrombin time (p = 0.019) than nonsmokers. Smoking did not appear to affect any of the parameters analyzed in females as no significant difference was found between smokers and nonsmokers (p > 0.05). Conclusion: Our results showed that smoking affected white blood cell count and von Willebrand factor levels in males and not in females, and as such could be potential markers for smoking-induced endothelial damage in asymptomatic Arab male smokers.

Copyright © 2008 S. Karger AG, Basel

  References

1.

Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.

2.

Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years' observations on male British doctors. Br Med J 2004;328:1519-1529.

3.

Blann AD, McCollum CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 1993;70:707-711.

4.

Blann AD, Lip GY: The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. Blood Coagul Fibrinolysis 1998;9:297-306.

5.

Pittilo RM: Cigarette smoking, endothelial injury and cardiovascular disease. Int J Exp Pathol 2000;81:219-230.

6.

Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y: Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 1999;93:271-278.

7.

Halfon ST, Green MS, Heiss G: Smoking status and lipid levels in adults of different ethnic origins: the Jerusalem lipid research clinic program. Int J Epidemiol 1984;13:177-183.

8.

Cullen P, Schulte H, Assmann G: Smoking, lipoproteins and coronary heart disease risk. Eur Heart J 1998;19:1632-1641.

9.

Tsiara S, Elisaf M, Mikhailidis DP: Influence of smoking on predictors of vascular disease. Angiology 2003;54:507-530.

10.

Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN: The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis 1998;141:133-139.

11.

Blann AD, McCollum CN: Von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg 1994;8:10-15.

12.

Blann AD: Is raised von Willebrand factor a marker of endothelial cell damage? Med Hypotheses 1993;41:419-424.

13.

Lip GY, Blann A: Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997;34:255-265.

14.

Blaes N, Piovella F, Samaden A, Boutherin-Falson O, Ricetti M: Nicotine alters fibronectin and factor VIII/vWF in human vascular endothelial cells. Br J Haematol 1986;64:675-687.

15.

Kalra J, Chaudhary AK, Prasad K: Increased production of oxygen free radicals in cigarette smokers. Int J Exp Pathol 1991;72:1-7.

16.

Prisco D, Fedi T, Brunelli L, Chiarugi L, Lombardi A, Gianni R, Santoro E, Cappelletti C, Pepe G, Gensini GF, Abbate R: The influence of smoking on von Willebrand factor is already manifesting in healthy adolescent females: the Floren-teen (Florence Teenager) study. Int J Clin Lab Res 1999;29:150-154.

17.

Kumari M, Marmot M, Brunner E: Social determinants of von Willebrand factor: the Whitehall II Study. Arterioscler Thromb Vasc Biol 2000;20:1842-1847.

18.

Gader A, Bahakim H, Awadallah S, Malaika S: Ethnic variations in the haemostatic system: comparison between Arabs, Westerners (Europeans and Americans), Asians and Africans. Blood Coagul Fibrinolysis 1995;6:537-542.

19.

Rastogi R, Shrivastava SS, Mehrota TN, Singh VS, Gupta MK: Lipid profile in smokers. J Assoc Physicians India 1989;37:764-766.

20.

Chand S, McCraw A, Hutton R, Tuddenham EG, Goodall AH: A two-site, monoclonal antibody-based immunoassay for von Willebrand factor: demonstration that vWF function resides in a conformational epitope. Thromb Haemost 1986;55:318-324.

21.

Waters D, Lesperance J, Gladstone P, Boccuzzi ST, Cook T, Hudgin R, Krip G, Higginson L: Effects of cigarette smoking on the angiographic evaluation of coronary atherosclerosis: a Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy. Circulation 1996;94:614-621.

22.

Smith MR, Kinmonth AL, Luben RN, Bingham S, Day NE, Wareham NJ, Welch A, Khaw KT: Smoking status and differential white cell count in men and women in the EPIC-Norfolk population. Atherosclerosis 2003;169:331-337.

23.

Kawada T: Smoking-induced leukocytosis can persist after cessation of smoking. Arch Med Res 2004;35:246-250.

24.

Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH: Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765-1773.

25.

Madjid M, Awan I, Willerson JT, Casscells SW: Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004;44:1945-1956.

26.

Loimaala A, Rontu R, Vuori I, Mercuri M, Lehtimaki T, Nenonem A, Bond MG: Blood leukocyte count is a risk factor for intima-media thickening and subclinical carotid atherosclerosis in middle-aged men. Atherosclerosis 2006;188:363-369.

27.

Tarallo P, Henny J, Gueguen R, Siest G: Reference limits of plasma fibrinogen. Eur J Clin Chem Clin Biochem 1992;30:745-751.

28.

Sinha S, Luben RN, Welch A, Bingham S, Wareham NJ, Day NE, Khaw KT: Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population. Eur J Cardiovasc Prev Rehabil 2005;12:144-150.

29.

Harmening, DM: Clinical Hematology and Fundamentals of Hemostasis. Philadelphia, Davis, 2002, pp 666-667.

30.

Kurata M, Sasayaman Y, Yamasaki N, Kitazawa I, Hamada Y, Horri I: Mechanism for shortening PT and APTT in dogs and rats-effects of fibrinogen on PT and APTT. J Toxicol Sci 2003;28:439-443.

31.

Murdock PJ, Woodhams BJ, Mathews KB, Pasi KJ: Von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to restocetin cofactor platelet agglutination assay for diagnostic use. Thromb Haemost 1997;78:1272-1277.

32.

Sukhu K, Poovalingam V, Mahomed R, Giangrande PL: Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease. Clin Lab Haematol 2003;25:247-249.

  Author Contacts

Dr. Anwar Al-Awadhi
Department of Medical Laboratory Sciences
Faculty of Allied Health Sciences, Kuwait University, PO Box 31470
90805 Sulaibekhat (Kuwait)
Tel. +965 498 3592, Fax +965 498 3835, E-Mail alawadhi@hsc.edu.kw

  Article Information

Received: February 19, 2007
Revised: April 24, 2007
Published online: February 19, 2008
Number of Print Pages : 5
Number of Figures : 0, Number of Tables : 1, Number of References : 32

  Publication Details

Medical Principles and Practice (International Journal of the Kuwait University Health Sciences Centre)

Vol. 17, No. 2, Year 2008 (Cover Date: February 2008)

Journal Editor: Owunwanne, A. (Kuwait)
ISSN: 1011-7571 (Print), eISSN: 1423-0151 (Online)

For additional information: http://www.karger.com/MPP

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.